Lorry Trans

Main Menu

  • Home
  • Trucking
  • Cargo
  • Shipping Transport
  • Air Freight
  • Capital

Lorry Trans

Header Banner

Lorry Trans

  • Home
  • Trucking
  • Cargo
  • Shipping Transport
  • Air Freight
  • Capital
Air Freight
Home›Air Freight›Tablo® Hemodialysis System Cartridge Receives FDA 510 (k) Clearance for Production in North America

Tablo® Hemodialysis System Cartridge Receives FDA 510 (k) Clearance for Production in North America

By Michael K. Davidson
November 29, 2021
0
0


Cartridge manufacturing at the new site localizes production, lowers costs and mitigates future supply chain risks

Departure Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, today announced that the United States Food and Drug Administration (FDA) has granted 510 clearance (k) for a new method of sterilizing the cartridge used in its Tablo® hemodialysis system, allowing full production in North America. The Tablo Cartridge is a single-use, disposable product that works in conjunction with the console to deliver dialysis therapy. Its “one touch” design makes it quick and easy to set up and remove therapy.

The new FDA clearance allows Outset to start production of cartridges through a manufacturing partner in Mexico, making it easier to locate the cartridge, in addition to the Tablo console, in North America. Additionally, the new location reduces the need for costly, limited capacity air transport of cartridges, simplifying distribution and logistics for the company, its customers and patients.

“This clearance is an important milestone on our roadmap for continued gross margin expansion,” said Leslie Trigg, President and CEO of Outset. “In addition to reducing costs, we are also better able to optimize our manufacturing process and mitigate current supply chain challenges with respect to lead time, capacity and logistics. ”

Another benefit of FDA clearance is the ability to start using an environmentally friendly method of sterilizing cartridges. The electron beam is a non-ionizing technology that can be produced on demand and does not involve toxic or potentially explosive chemicals. Further details on Outset’s sustainability efforts can be found in the company’s recently released report. ESG report.

About Outset Medical, Inc.

Outset is a medical technology company developing unique technology to reduce the cost and complexity of dialysis. The Tablo hemodialysis system, approved by the FDA for home hospital use, represents a significant technological advance that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a unique business solution that can be used across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. Integration of water purification and on-demand dialysate production enables Tablo to serve as a wheeled dialysis clinic, with two-way wireless data transmission and a proprietary data analysis platform fueling a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Forward-looking statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements regarding Outset’s strategy, plans and objectives. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, which could cause actual results and other events to differ materially from those expressed or implied in such statements. These risks and uncertainties include the risks described in the Risk Factors section of Outset’s latest annual report on Form 10-K and the quarterly report on Form 10-Q filed with the United States Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. Outset disclaims any obligation to update these forward-looking statements.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20211129005195/en/


Related posts:

  1. Taiwan’s China Airlines says pilot quarantines will impact cargo operations
  2. Air Cargo Container Market Forecast to 2027
  3. Air Cargo Unit Loading (ULD) Device Market Report 2021 by Global Key Players, Types, Applications, Countries, Size, Forecast Till 2027
  4. US and Canadian pilots’ unions fight over Cargojet and fatigue rules
Tagsnorth americapress releaseunited states

Recent Posts

  • Cargo Handling Equipment Market Size, Scope and Forecast
  • Latest news on the Russian-Ukrainian war: live updates
  • Webcast: In a post-lockdown world, these strategies offer exposure to the transport rebound
  • Payday Loan Service: Market Growth Expected to Increase Significantly from 2022 to 2028
  • Deliveree is smoothing out Southeast Asia’s bumpy logistics landscape – TechCrunch

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Air Freight
  • Capital
  • Cargo
  • Shipping Transport
  • Trucking
  • Terms and Conditions
  • Privacy Policy